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In Brief Choudhury et al. show that Gg subunits, besides acting as anchors for their obligate Gb subunits, have more complex roles in regulating G protein signaling. Furthermore, they show that this tuning of G protein signaling by the phosphorylated Gg N-terminal tail is achieved by altering the interaction between Gbg and downstream effectors in a PTM-dependent manner. 
INTRODUCTION
Canonical G protein signaling systems-including 7-transmembrane G-protein-coupled receptors (GPCRs), heterotrimeric G-proteins (Gabg), and diverse effector proteins-constitute a highly conserved system enabling the transduction of extracellular signaling molecules such as hormones, neurotransmitters, and chemokines (Cabrera-Vera et al., 2003; Wettschureck and Offermanns, 2005) . As one of the primary signal transduction mechanisms in eukaryotes, G protein signaling pathways control a wide range of processes in both single-cell and multi-cellular organisms such as yeast and humans (Bargmann, 2006; Fan et al., 1997; Kaul et al., 2001; Rockman et al., 2002; Rosenbaum et al., 2009 ). Owing to their high degree of structural conservation, fundamental mechanisms underlying the regulation of G protein signaling have emerged from empirical studies conducted across widely diverse organisms from yeast to human. Such attributes have also helped to solidify their prominent role as pharmaceutical targets for the treatment of human disease (Hauser et al., 2017 ).
The yeast model system for G protein signaling remains one of the most well-characterized signaling pathways in history and has been instrumental in the discovery of G protein regulatory mechanisms, including regulators of G protein signaling (RGS) proteins and post-translational-modification (PTM)-based regulators (Cappell et al., 2010; Clement et al., 2013; Deflorio et al., 2013; Dohlman et al., 1991 Dohlman et al., , 1996 Dohlman and Thorner, 2001; Isom et al., 2013; Li et al., 1998; Stone et al., 1991; Wang et al., 2005) . In budding yeast Saccharomyces cerevisiae, a single canonical G protein signaling pathway controls the process of mating, wherein two yeasts of opposite and complementary mating types, MATa and MATa, fuse to form an a/a diploid cell (Dohlman and Thorner, 2001) . As in the case of multicellular organisms, including mammals, G protein signaling in yeast is initiated by agonist-dependent activation of a GPCR at the cell surface (Dohlman and Thorner, 2001) . In MATa cells, a single peptide mating pheromone (a factor) serves as the agonist of the pheromone GPCR, Ste2, and upon binding promotes the exchange of GDP for GTP on the Ga subunit (Gpa1). GTP binding stabilizes a conformational change in Ga and dissociation of the heterotrimer into Ga and Gbg (Ste4/Ste18) components (Dohlman and Thorner, 2001; Sprang, 1997) . In yeast, Gbg serves as the primary activator of the mating pathway, whereas Ga serves primarily to sequester Gbg (Dohlman and Thorner, 2001) . When not sequestered, Gbg nucleates the formation of a protein complex at the plasma membrane that includes a p21-activated protein kinase (PAK; Ste20) and a protein scaffold (Ste5) in complex with a mitogen-activated protein kinase (MAPKKK) (Ste11), MAPKK (Ste7), and mitogen-activated protein kinase (MAPK) (Fus3), as well as additional proteins important for cell polarization (Arkowitz, 2009; Nern and Arkowitz, 1999) . Activation of the pheromone response pathway through this process drives a phosphorylation cascade resulting in double phosphorylation (referred to here as di-phosphorylation or activation) of Kss1 T183,Y185 and Fus3 T180,Y182 -highly conserved orthologs of the human MAPKs Erk1 and Erk2-which phosphorylate several targets necessary for a complete mating response. Once activated, Fus3 translocates to the nucleus, wherein it phosphorylates the transcription factor Ste12 and other proteins necessary to drive a gene transcription program resulting in morphological change, cell-cycle arrest, and eventual mating (van Drogen et al., 2001; Elion et al., 1993) . Signaling is terminated by hydrolysis of GTP to GDP on the Ga subunit and re-association of the heterotrimeric complex, a process that is accelerated by the RGS protein (Sst2) (Dohlman et al., 1996) .
Several aspects of pheromone pathway behavior-such as switch-like versus graded dose-responsiveness and differential activation of MAPKs Fus3 and Kss1-have been linked directly to the Ste5 scaffold, which plays a major role in nearly all aspects of pathway control. Ste5 contains multiple domains that effectively tune the pheromone activation profile of Fus3, which binds to Ste5, distinctly from Kss1, which does not (Figure 1 ). The Fus3-binding domain (FBD) plays a critical role in this process by allosterically activating the autophosphorylation of Fus3 Y182 (referred to here as mono-phosphorylation) in a manner independent of pheromone stimulation (Bhattacharyya et al., 2006) . Mono-phosphorylated Fus3 phosphorylates Ste5 T287 and three other phosphosites proximal to the RING domain, which functions to inhibit full activation of Fus3 and the mating pathway (Good et al., 2009) . Inhibition is relieved in part by the action of the pheromone-dependent phosphatase, Ptc1, which competes with Fus3 for FBD binding and dephosphorylates Ste5, failure of which (ptc1D) prevents activation of Fus3 (Malleshaiah et al., 2010) . Within the context of G protein signaling, Gg subunits have been largely understood as membrane anchors for Gb subunits and rarely have been studied in any other context. Phosphorylation of Gg12 has been shown to enhance the affinity of Gbg for Ga subunits in vitro (Morishita et al., 1995) and impact the activity of the Gbg12 dimers toward specific effectors (Yasuda et al., 1998) . Recently, we showed that Gg subunits across all eukaryotes harbor at least 2 phosphorylation sites in their intrinsically disordered N-terminal tails, many of which have also been observed as phosphorylated in high-throughput proteomics screens (Dewhurst et al., 2015) . Here, we show that the N-terminal tail of the yeast Gg subunit, Ste18, together with the Fus3/ Ste5 FBD docking interaction, constitute a negative regulatory system that synergistically controls the activation of Fus3 and Kss1 through a dynamic phospho-inhibitory mechanism that prevents rapid and stable association of bulk Ste5 at the plasma membrane. Disruption of either side alone (by point mutation of Ste18 Nt or Ste5 FBD ) results in minor but significant and reciprocal changes to the rate and amplitude of Fus3 activation and Ste5/ PM recruitment, whereas combined disruption of both elements results in ultra-rapid and robust Fus3 activation and Ste5/PM recruitment. We show that negative regulation is facilitated by weakened binding between Gbg and Ste5 when both proteins are phosphorylated-a mechanism that may have emerged through co-evolution of the two distinct phospho-regulatory elements. Taken together, these data reveal a way in which Gbg/ effector binding can be modulated to control signaling output through post-translational modification.
RESULTS
The N-Terminal Tail of Ste18 Is Rapidly Phosphorylated in Response to GPCR Activation Like other Gg subunits throughout Eukarya, the terminal ends of Ste18, representing 20% of its residue content, are intrinsically disordered-most of which correspond to the N-terminal tail (Ste18 Nt ). This region in Ste18 (residues 1-13) harbors phosphorylation sites at Thr-2, Ser-3, and Ser-7, specifically (Dewhurst et al., 2015; Soufi et al., 2009) 
. Phosphorylation of Ste18
Nt produces a distinctive electrophoretic mobility shift in response to pheromone stimulation, which can be detected by SDS-PAGE and immunoblotting (Dewhurst et al., 2015) . Treatment with alkaline phosphatase eliminates the mobility shift in a manner that depends on the presence or absence of phosphatase inhibitors (Figure S1A ; referred to here as Ste18 3E ) eliminate or restore the mobility shift, respectively (Dewhurst et al., 2015) . To determine a precise estimate of phosphorylation kinetics early and late after receptor activation, we surveyed the phosphorylationdependent mobility shift of Ste18 in both long and short time course experiments (Figures 2A and S1B ). We found that phosphorylation occurs almost instantaneously after receptor activation and is readily detectable within 30 s ( Figures 2B and S1B ). Maximum phosphorylation is achieved at $80% of total Ste18 levels within 3 min, with time at half maximum (t 1/2 ) of 1.25 min ( Figure 2B and Kss1 MAPKs were consistent with their expected patterns of activation at 3-mM pheromone concentrations (Figure 2C) (Hao et al., 2008) .
Surmising that Ste18 phosphorylation may depend on a kinase within the pheromone pathway, we monitored Ste18 phosphorylation in cells lacking single components of the pathway, including: Ste20, Ste11, Ste7, Fus3, and Kss1, in addition to the MAPK scaffold Ste5. We found that all kinases upstream of and including the scaffolded MAPK complex were necessary for robust phosphorylation of Ste18
Nt in response to pheromone (Figures S1C and S1D) . Kss1, which is rapidly phosphorylated after receptor activation but is not scaffolded by Ste5, is not required for pheromone-dependent Ste18 phosphorylation. Since Ste18 phosphorylation should not be lost in fus3D cells if MAPKs upstream of Fus3 are responsible for phosphorylation, these data suggest that Fus3, but not upstream MAPKs, are necessary. Other genes involved in the pheromone pathway that either regulate pheromone dependent kinase activation or are themselves pheromone-activated kinases had little to no effect when deleted from the genome ( Figure S2 ). Taken together, these data demonstrate that Ste18 is rapidly phosphorylated in response to GPCR activation in a manner that requires Fus3.
Phosphorylation of Ste18
Nt and Ste5 Function Figures S3A and S3B) . Thus, Ste18 phosphorylation is required for delayed peak activation of the scaffolded MAPK Fus3 but has no effect on the activation of the un-scaffolded MAPK, Kss1.
Negative feedback phosphorylation of Ste5, like phosphorylation of Ste18, occurs early/before the mating response and also requires Fus3. Therefore, we hypothesized that both elements may function in concert to delay Fus3 peak activation. This hypothesis was inspired, in part, by two points of indirect evidence that converge on Fus3 as a negative regulator of the pheromone response. First, rapid receptor-activated phosphorylation of Ste18
Nt requires Fus3 ( Figure S1 ), and activated Fus3 has been previously shown to counteract the stability of Ste5/PM association during the pheromone response (Yu et al., 2008b) . Second, Fus3-mediated negative feedback phosphorylation on Ste5 dampens the intensity of Fus3 activation in response to pheromone (Dowell et al., 1998; Hao et al., 2008; Inouye et al., 1997) . Additionally, we considered as further evidence that stable Ste5/PM association is facilitated in part by the interaction of the Ste5 RING domain (Ste5 ) with residues in Ste4 (Ste4 [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] ) that are located in the coiled-coil structure formed by both Gb (Ste4) and Gg (Ste18) subunits and in very close proximity to where phosphorylation occurs in Ste18
Nt (Dowell et al., 1998 Figure 3E ; Table S2 ). Significantly, this response was 25 min earlier and nearly 1.5-fold greater in amplitude than observed for Ste5 ND alone and 3.6-fold greater than the response in wild-type cells ( Figure 3E ; Table  S2 ). Neither this nor any other mutant showed abrupt differences in the pattern of pheromone-dependent Fus3 expression level compared to wild-type cells, suggesting that differences in the intensity of activated Fus3 at early time points is due to Fus3 phosphorylation and independent of Fus3 expression (Figure S4A Figure 3D ). Further confirmation of these results was achieved by endpoint immunoblot assays conducted within the first 15 min of pheromone stimulation ( Figures S4C-S4E ).
Evidence from MAPK activation analysis suggested that Ste18 and Ste5 phosphorylation behave synergistically so that the combined effect of both produces an effect that is greater than the sum of their separate effects. Indeed, a quantitative test for synergy revealed that phosphorylated Ste18 and Ste5 are synergistic in their control of Fus3 peak activation time but additive in their control of Fus3 peak amplitude, with an overall synergistic impact that is $43 greater than the sum of effects contributed by Ste18 or Ste5 alone (Table S2) . Taken together, these data suggest that the phosphorylation of Ste18 and MAPK docking/phosphorylation of Ste5 (referred to here as the Ste18/Ste5 phospho-inhibitory system) synergize to delay the activation and repress the amplitude of Fus3 activation in response to pheromone.
Together, Ste18/Ste5 Phosphorylation Delays Bulk Recruitment Rate and Reduces the Duration of Ste5/PM Association Activation of Fus3 requires recruitment and stable association of Ste5 with the plasma membrane, and consequently, mutations that disrupt or enhance Ste5/PM association should be reflected by the kinetics and amplitude of Fus3 activation. To test this hypothesis, we monitored Ste5/PM association by fluorescence microscopy before, during, and after pheromone stimulation of yeast cells. We were unable to detect Ste5-GFP at the PM in any cell that was not treated with pheromone ( Figure 4A , top). However, in as few as 23-26 min after pheromone stimulation, we observed robust PM accumulation of Ste5-GFP in all cell types, most noticeably in Ste18 3A /Ste5 ND cells ( Figure 4A , bottom). Consistent with our hypothesis, preventing phosphorylation on both Ste18 and Ste5 (Ste18 3A /Ste5 ND ) resulted in the robust accumulation of Ste5-GFP at the PM after 25 min of pheromone stimulation, reaching a level nearly 7-fold greater than that of wild-type cells measured at the same time ( Figure 4B ). However, no differences were observed in the protein levels of Ste5-GFP ( Figure S6 ). Thus, the Ste5-GFP signal at the membrane reflects altered Ste5/PM accumulation rather than protein stability. Furthermore, these data suggest that the bulk recruitment rate of Ste5 to the PM-reflected in the number of Ste5-GFP molecules that accumulate at the PM per unit time (i.e., total fluorescence intensity/time)-is significantly faster when phosphorylation on both proteins is prevented.
To compare the relative rates and stability of Ste5-GFP/PM accumulation at the population level, we quantified the percentage of the cell population with Ste5-GFP localized at the PM as a function of time. Measured in this way, Ste5/PM accumulation data are Table S3 ). Taken together, these data suggest that phosphorylation on Ste18 regulates the morphological mating switch in cells when Ste5 is incapable of docking with Fus3. Furthermore, these data suggest that Ste18/Ste5 phosphorylation regulates the switch-like mating decision in yeast.
Phosphorylation of the Gg Subunit and MAPK Docking on Ste5 Appear Simultaneously in the Phylogeny of Yeasts
Recent phylogenetic and experimental evidence has revealed that the Ste5 FBD arose $130 million years ago and is almost exclusively found in the clade to which Saccharomyces cerevisiae belongs but is also partially extant in V. polyspora species, which contain a partial FBD that is moderately active (Coyle et al., 2013) . Having determined that the phosphorylation of the N-terminal tail of Ste18 and the Ste5 FBD function synergistically to control signaling, we asked whether these two structural elements may have co-evolved. Comparison of the phylogeny of Ste18 and Ste5 fungal orthologs revealed compelling evidence in support of this hypothesis. Indeed, the appearance of the phosphorylation sites in the Ste18 intrinsically disordered region (phospho-IDR) coincides with the appearance of Ste5 FBD ( Figures 6A and S7A ). Furthermore, all extant members of the clade retain nearly 100% identity for sites of phosphorylation and MAPK binding that are essential to either element ( Figure 6B) . A somewhat similar putative phospho-IDR was also found in the Ste18 ortholog from S. castellii and the distantly related Y. lipolytica, both species of which harbor 2 of the 3 phosphosites observed in The morphological dose-response to mating pheromone represented by the cellular formation of a mating projection (i.e., shmoo) was quantified as a percentage of total cells in a population by DIC microscopy. S. cerevisiae but exhibit dramatically different N-terminal IDR lengths ( Figure S7B ). When looking strictly within the phylogeny of Ste5-containing yeast species (excluding A. gossypii, which harbors an extraordinarily long N-terminal IDR), we observed a progressive lengthening over time of the N-terminal IDRs of Ste18 orthologs, culminating in a dramatic increase of 8-10 amino acid residues that appeared coincidently with the Ste5 FBD (Figure S7C) . Taken together, these data suggest that Ste18 and Ste5 phospho-regulatory elements arose at similar times and appear only once in the evolution of budding yeast.
DISCUSSION
Gg subunits are recognized as having limited function as membrane anchors for Gb subunits in heterotrimeric G protein signaling systems (Cook et al., 1998; Kisselev et al., 1995; Muntz et al., 1992 (Coyle et al., 2013) . See also Figure S7 .
vealed that Gg N-terminal tails are prominent targets of phosphorylation, indicating that they might also possibly be important signal regulators (Dewhurst et al., 2015) . Here, we have demonstrated that phosphorylation of the Gg subunit in yeast regulates G protein signaling through a feedback phosphorylation mechanism that synergizes with MAPKdocking-dependent phosphorylation on the protein scaffold Ste5.
New Insights into the Regulation of Ste5/PM Association and MAPK Activation For good reason, understanding the mechanism by which Ste5 coordinates mating pathway output has been a long-standing endeavor with many revisions over the past 10-15 years. The primary function of Ste5 is to properly translate stimulus dose to MAPK response signals-a function that is facilitated by scaffolding of the MAPK cascade module (MAPKKK Ste11, MAPK Ste7, and MAPK Fus3). In resting cells, Ste5/MAPK and Ste5 inter-domain interactions, as well as phosphorylation, prevent signaling from occurring spontaneously. Under such conditions, Ste5 is distributed between the cytoplasm and the nucleus-a phenotype that is cell-cycle regulated in part (Maeder et al., 2007; Strickfaden et al., 2007) . Cytoplasmic Ste5 can still interact with all three components of the MAPK cascade module (Takahashi and Pryciak, 2008 WT ) produces an equivalent enhancement in peak activation and amplitude that is 2 times faster and 1.5 to 2 times more intense than in wild-type cells ( Figure 3E ). Disabling both elements (Ste18 3A /Ste5 ND ) results in ultra-fast and intense Fus3 activation that is 6 times faster and 3-4 times greater than the wild-type response. We show further that the response in MAPK activation for these mutants correlates very well with the bulk rate and duration of Ste5/PM association, indicating that it is the dominant control factor for the Fus3 activation profiles observed in each mutant.
Considering our body of evidence in light of previous work by others, we propose a model in which the activation/deactivation of the Ste18/Ste5 phospho-inhibitory system is regulated differentially ( Figure 7A ). In a pre-stimulated state, Fus3 is monophosphorylated and, in this state, is capable of phosphorylating Ste5 at up to 4 positions near Ste5 FBD ( Figure S5 ; Malleshaiah et al., 2010) , while Ste18 is also basally phosphorylated (Figures  2 and S1 ). This suggests that inhibition is partially engaged even before a pheromone stimulus. Upon the addition of pheromone, the Ste18/Ste5 inhibitory elements become fully activated, as both Ste18 and Ste5 become hyper-phosphorylated, demonstrated herein directly for Ste18 (Figure 2 ) and presumed by an in vitro Fus3 kinase assay with Ste5 (see Figure S9 in Malleshaiah et al., 2010) . We propose that this constitutes the fully activated inhibitory element that is responsible for bulk inhibition of Ste5/ PM association early in the pheromone response, as determined from the relative amounts of Ste5-GFP/PM accumulation observed in Ste18 Simultaneously, pheromone stimulates recruitment of Ptc1 phosphatase to Ste5 FBD , which outcompetes Fus3 binding within 2 min post-stimulus and dephosphorylates the inhibitory feedback phosphosites on Ste5 (see Figure S18 in Malleshaiah et al., 2010) . Since as few as one occupied Ste5 phosphosite leads to the inhibition of Fus3 di-phosphorylation (Malleshaiah et al., 2010) , it is presumed that all four sites must be completely Nt and Ste5 FBD Constitute a Dynamic Phosphoregulatory System for Pheromone Signaling (A) In response to pheromone, Ste18 is rapidly phosphorylated at its N-terminal tail (P-lollipop). Ste5 is simultaneously phosphorylated via negative feedback controlled by Fus3/Ste5 FBD docking (P-lollipops). Together, this constitutes a phospho-inhibitory system that prevents otherwise rapid Ste5/PM association.
While not shown outright here, previous work implicates pheromone-stimulated expression of Ptc1 phosphatase and removal of inhibitory phosphorylation on Ste5 as the inhibition release (Malleshaiah et al., 2010 ) (dashed orange box). Consequently, the mating pathway is activated with a kinetic delay, as evident by the slower rate of Ste5 association at the membrane and delayed peak activation of Fus3. (B) Cells engineered to prevent activation of the Ste18/Ste5 system (Ste18 3A /Ste5 ND ) respond $6 times faster with $4 times greater intensity than observed in wild-type cells-a response that demonstrates synergy between the two phospho-regulatory elements (phosphorylated Ste18 and Ste5) in the system. dephosphorylated. We propose that this constitutes a release by partial de-inhibition of the Ste18/Ste5 inhibitory element, which leaves the Ste18 element intact (phosphorylated), as can be seen by the fact that Ste18 phosphorylation remains unchanged during this time ( Figure 3B) . We propose that, as a consequence of having one phospho-inhibitory element still intact (phosphoSte18), the bulk recruitment of Ste5 to the membrane is permitted but relatively slow, and the activation of Fus3 is delayed, not reaching peak amplitude until $30 min post-stimulus ( Figures 2C, 3E, and 4) . This half-activated state of the Ste18/ Ste5 system also controls the degree to which Ste18 co-immunoprecipitates with Ste5 and the degree to which Ste5/PM association occurs ( Figure 4G) Figure 7B ). Consequently, Fus3 activation in this state appears to match the profile of Kss1 activation, which is not scaffolded ( Figures  3D and 3E) . Again, the rapid bulk recruitment of Ste5 under these conditions ( Figure 4 ) can explain this effect, since rapid Ste5/PM association is known to drive rapid de-inhibition of the Ste5 VWA domain by promoting the association of Ste5 PH with the plasma membrane-a mechanism that has been demonstrated previously by the Wendell Lim lab as an essential step to drive phosphorylation of Fus3 by Ste7 (Zalatan et al., 2012) . Switch-like behavior of the pathway is also modulated, in part, by the Ste18/Ste5 phospho-inhibitory system, which controls Ste5/ PM association, an observation that is consistent with previous reports demonstrating that Ste5 FBD and Ste5/PM association regulate hill slope (Coyle et al., 2013; Takahashi and Pryciak, 2008) . Several pieces of evidence, both from our work and others, suggest that Fus3 is the major (if not primary) kinase for activating the phospho-inhibitory system. Fus3 phosphorylates proline +1 sites on Ste5 (Bhattacharyya et al., 2006) and on Ste18
Nt ( Figures S3C and S3D )-of which, both sites emerged at the same time in the evolution of budding yeast (Figure 6 ). Second, Ste5/PM association is enhanced in fus3D compared to FUS3 cells treated with pheromone (Yu et al., 2008a )-a phenotype that we also observe for the phospho-null mutant Ste18 3A /Ste5 ND (Figure 4 ). Third, inhibition of an analog-sensitive form of Fus3 (fus3-as2) serves to stabilize Ste5/PM association upon pheromone stimulation (Yu et al., 2008b) . Consequently, a Fus3-specific phosphatase such as Msg5, which has been suggested to synergize with Ste5 to repress Fus3 activation (Nagiec et al., 2015) , will alter the ability of Fus3 to function as an activator of the system. Indeed, deletion of the Msg5 phosphatase in Ste5 ND cells (Ste5 ND /msg5D) results in more intense, but not faster, Fus3 activation compared to wild-type or either mutation alone (Nagiec et al., 2015) , consistent with long-standing evidence that deletion of Fus3-specific phosphatases permits intense and prolonged Fus3 activation (Zhan et al., 1997) . Thus, modulation of Fus3 activity necessarily imparts both positive (gene transcription) and negative (Ste18/Ste5) feedback on the pheromone pathway, which will be affected by inhibition or deletion of the kinase.
Gg N-Terminal Tails as Regulators of G Protein Signaling-from Yeast to Humans
Our data reveal the potential for Gg subunits to play more intricate roles in regulating G protein signaling, effective through PTM-altered protein interactions. As stated earlier, most eukaryotic Gg subunits are phosphorylated in their N-terminal tails, and all Gg subunits have the potential to be phosphorylated, since serine and threonine are ubiquitous in eukaryotic Gg subunit N-terminal tails (based on data curated and reviewed by UniProt) (Dewhurst et al., 2015) . In yeast, we find that phosphorylation plays a major role in effector recruitment, but we do not observe evidence that it impacts heterotrimer association, which can be sensitively detected by monitoring Fus3 activation in yeast. This is consistent with previous reports that negative feedback by Fus3 does not impact heterotrimeric G protein dissociation (Yu et al., 2008b) . Thus, functional, GPCR-activated phosphorylation of Gg N-terminal tails is not a process restricted to yeast and, as we have shown here, can regulate G protein signaling output by modulating Gbg effector binding.
EXPERIMENTAL PROCEDURES Yeast Strains and Plasmids
Standard methods for cell growth, maintenance, and transformation of yeast and for the manipulation of DNA were used throughout. Strain BY4741 (MATa leu2D met15D his3D ura3D )-and BY4741-derived mutants were used. Details of strains used are listed in Table S1 . Strains were constructed using the two-step dellitto perfetto mutagenesis method (Storici and Resnick, 2006) and confirmed by dideoxy sequencing. LRB341 and LRB345 strains harboring yck1D and temperature-sensitive yck2 ts alleles were graciously provided by Dr. Lucy Robinson (Robinson et al., 1993) . Plasmids used in this study for kinase deletion screening (pRS316-CUP1-HA-STE18) were graciously provided (a gift from T. Chernova). The detailed method of strain construction is provided in the Supplemental Information.
Yeast Cell Culture and Treatments
Yeast strains were grown in YPD growth medium (yeast extract, peptone, 2% dextrose media), unless otherwise noted. All experiments were conducted with log-phase cells with an optical density at 600 nm (OD 600 ) between 0.75 and 0.85 and stimulated with a-factor peptide hormone (GenScript) at a 3-mM final concentration, if required. Cells were harvested with trichloroacetic acid (5% final v/v) and frozen at À80 C.
For kinase screening, deletion strains carrying the pRS316-CUP1-HA-STE18 plasmid were grown in synthetic media lacking uracil and other appropriate amino acids as necessary. Expression of HA-STE18 was induced by 100 mM copper sulfate, and cells were stimulated as described earlier. The detailed procedure is provided in the Supplemental Information.
Cell Extracts and Immunoblotting
Proteins were extracted by glass bead lysis in trichloroacetic acid (TCA) as previously described (Lee and Dohlman, 2008) . Protein concentration was determined by the DC Protein Assay (Bio-Rad). Protein extracts were resolved by 7.5% or 12.5% SDS-PAGE and immunoblotted with epitope-specific antibodies (see entire list in the Supplemental Information). Note that the current lot of Phospho-p44/42 MAPK antibody (Cell Signaling Technologies catalog #9101) exhibits reduced detection sensitivity for activated Fus3 compared to activated Kss1, which affects the ability to detect Fus3 activation in the very early stages of a pheromone response (i.e., before 1 min). Horseradishperoxidase (HRP)-conjugated secondary antibodies (goat-anti-rabbit, goatanti-mouse, or rabbit-anti-goat) were used for the detection of reactant bands by chemiluminescence with ECL reagent (PerkinElmer catalog #NEL 104001EA). Immunoblots were quantified by high-resolution scanning and pixel densitometry using ImageJ software (Schindelin et al., 2015) .
Morphological Response Assay
The morphological response of STE18/STE5 mutants to a-factor was measured as described previously (Coyle et al., 2013; Malleshaiah et al., 2010) and detailed in the Supplemental Information. The morphology of the cells was determined, 3 hr post-pheromone stimulation, by differential interference contrast (DIC) confocal microscopy using a PerkinElmer UltraVIEW spinning disk confocal microscope. The number of cells with mating projections was counted as a percentage of total.
Ste5-GFP Localization Assay
Live cells endogenously expressing either Ste5-GFP or Ste5 ND -GFP were visualized by microscopy. To ensure visibility across all strains, we exposed cells to 10 mM a-factor followed immediately by deposition onto agar pads saturated with 30 mM a-factor. Once deposited, cells were monitored using a PerkinElmer UltraVIEW VoX spinning disk confocal microscope. A detailed procedure for image acquisition and quantification is provided as Supplemental Information.
CoIP
Cells endogenously expressing different combinations of wild-type or mutant hemagglutinin epitope (HA)-STE18 and STE5-GFP were treated with 10 mM pheromone for 20 min followed by cell lysis and coIP using anti-GFP monoclonal antibody (mAb)-agarose (MBL International, #D153-8). Eluted proteins were separated by SDS-PAGE and immunoblotting with anti-GFP (Invitrogen, A11122) and anti-HA (Supplemental Information).
Phylogenetic Analysis
Ascomycota protein sequences were retrieved from the Broad Institute Fungal Orthogroups Repository (https://portals.broadinstitute.org/regev/orthogroups/ ). Multiple sequence alignments were achieved using MUSCLE with default parameters (Edgar, 2004) . Phylogenetic and graphical analyses of Ste18 and Ste5 sequence alignments were achieved using Unipro UGENE software (Okonechnikov et al., 2012) . Bootstrap consensus trees were prepared using 100 (shown) and 500 (not shown) iterations. Presence or absence of Ste5 or the Ste5 FBD was determined from a combination of sequence alignment homology and previous phylogenetic analyses of Ste5 (Coyle et al., 2013) .
Statistical Analysis
Statistical analysis for quantifying immunoblots and microscopy data was achieved using Prism software, v6/7 (GraphPad Software). Statistical significance was determined by ANOVAs. (Dewhurst et al., 2015) , using the two-step dellitto perfetto mutagenesis method (Storici and Resnick, 2006) . Briefly, a CORE cassette comprising of counter selectable marker and reporter gene was inserted via homologous recombination, in the 829-990 region of STE5 coding sequence containing the Fus3 docking region on the protein. The CORE cassette was later replaced by oligonucleotides containing the desired mutations and regions of homology to STE5. Similarly, GFP-tagged STE5 strains were constructed by integrating a CORE cassette at the 3-prime end of STE5 and replacing it with the coding sequence for Green Fluorescent Protein (GFP). Strains were verified at each step by PCR amplification and dideoxy sequencing (Eurofins MWG Operon). LRB341 and LRB345 strains harboring yck1D and temperature-sensitive yck2 ts alleles were graciously provided by Dr. Lucy Robinson (Robinson et al., 1993) . Plasmids used in this study for kinase deletion screening (pRS316-CUP1-HA-STE18), were graciously provided (gift from T. Chernova).
SUPPLEMENTAL INFORMATION
Yeast cell culture and treatments -Yeast Strains were grown in YPD growth medium (Yeast Extract, Peptone, 2% Dextrose media) unless otherwise noted. Cells were grown at 30C with shaking at 250 rpm and cell culture density was determined by absorbance at 600nm (OD600). All experiments were conducted with log phase cells between OD600 0.75-0.85. Log-phase cells were then treated with a-factor peptide hormone (Genscript) at 3µM final concentration. 10ml aliquots of treated cells were harvested with 0.5ml trichloroacetic acid (TCA) on ice and centrifuged at 3724 x g in Allegra X-14R Beckman Coulter Centrifuge. Cells were then washed with 10ml MiliQ water, followed by transfer to microcentrifuge tubes that were immediately frozen at -80C.
For kinase screening, deletion strains carrying the pRS316-CUP1-HA-STE18 plasmid were grown in synthetic media lacking uracil and other appropriate amino acids as necessary. An overnight saturated culture was then diluted to OD600 0.05 and allowed to grow until OD600 0.2. Expression of HA-STE18 was then induced by addition of 100µM copper sulfate. Cells were grown till log-phase (OD 0.75-0.85), followed by treatment with 3µM a-factor for an hour. The cells were harvested with TCA as described earlier. For yck ts strains, HA-STE18 expression was induced as above. At OD600 0.8, each culture was split into two parts: One subjected to pheromone treatment and the other incubated at 37C for 30 minutes prior to stimulation with pheromone.
Cell extracts and Immunoblotting -Protein extracts were resolved by 7.5% or 12.5% SDSPAGE and immunoblotted with epitope-specific antibodies specific to: the hemagluttinin antigen epitope (HA) (Cell Signaling Technologies, Cat #3724) at 1∶5000; activating phosphorylated sites in Fus3 and Kss1 (Phospho-p44/42 MAPK) (Cell Signaling Technologies, Cat #9101) at 1∶500; Fus3 protein (Santa Cruz, anti-Fus3 yC-19, Cat # sc-6773) at 1:350; Kss1 protein (Santa Cruz, anti-Kss1 yC-19, Cat # sc-6775R) at 1:1500; GFP (Invitrogen, Cat# GF28R MA5-1526-HRP) at 1:1000; and glucose-6-phosphate dehydrogenase (loading control; LC) (Sigma-Aldrich, Cat #A9521) at 1∶50,000.
Phosphatase Assay -Pheromone-treated cells were harvested as described earlier. The frozen pellets were resuspended in 1x phosphatase buffer mix (New England Biolabs), comprising of 1x PMP buffer (50mM HEPES (pH 7.5), 100mM NaCl, 2 mM DTT, 0.01% Brij 35), 1mM MnCl2, and 1x EDTAfree protease inhibitors (Roche). The resuspended pellet were equally aliquoted into three tubes-Control, AP (Alkaline phosphatase), and AP/I (Alkaline phosphatase Inhibitor). Each resuspended pellet was subjected to glass bead lysis in the absence (Control and AP sample) or presence (AP/I sample) of phosphatase inhibitors (50mM NaF and 1.3mM sodium orthovandate). The lysates were centrifuged at 21.1 x g in Thermo Pico21 centrifuge and the supernatant was collected in a fresh tube. The AP and AP/I samples were treated with phosphatase enzyme (final concentration of 2.25U/µl) for 30 mins at 30C; whereas the control sample was left untreated. The reaction was stopped by addition of 6x SDS loading dye, and the samples were immediately run on SDS-PAGE gel and subjected to immunoblotting.
Phos-tag gel analysis -Protein extracts were resolved by 100µM Mn 2+ -Phos-tag in 7.5% acrylamide SDS-PAGE as per manufacturer's instructions (Wako Chemicals, Richmond, VA). The gel was run at a constant current of 30 mA per gel till dye ran off. Next, the gel was soaked in transfer buffer (0.125M tris, 0.96M glycine, 20% methanol v/v) containing 1mM EDTA, and later in transfer buffer without EDTA for 30 min each with gentle shaking. This process chelates Mn 2+ and increases transfer efficiency of both phosphorylated and non-phosphorylated proteins. Wet-tank transfer in buffer containing 0.1% SDS was used to effectively transfer proteins onto nitrocellulose membrane. The proteins were then subjected to immunoblotting.
Morphological response assay -The morphological response of STE18/STE5 mutants to a-factor was measured as described previously (Coyle et al., 2013; Malleshaiah et al., 2010) . Briefly, an overnight culture was washed twice with MilliQ water, and then diluted to an OD600 0.05 in synthetic complete (SC) media. After 4h of growth at 30C with shaking at 250 rpm, the cultures were distributed into separate tubes, and serially diluted pheromone was added to each. The morphology of the cells was determined, 3h post-stimulation, by differential interface contrast (DIC) confocal microscopy using a PerkinElmer UltraVIEW spinning disk confocal microscope. Number of cells with mating projections were counted as a percentage of total.
Ste5-GFP localization assay -Live cells endogenously expressing either Ste5-GFP or Ste5 ND -GFP were visualized by microscopy. Log phase cultures (OD 600 0.7-0.8) grown in SC media were briefly sonicated, centrifuged, and resuspended in SC media containing 10µM a-factor. Cells were immediately mounted on a SC agar (2.5%) pad with 30µM a-factor and the GFP fluorescence was monitored for 200 minutes. Cells were visualized by fluorescence microscopy using a PerkinElmer Ultraview VoX spinning disk confocal scanner with a Hamamatsu ORCA FLASH 4 camera on a Nikon Ti-e microscope stand. Photomicrographs were obtained using a 60x NA 1.49 apochromatic objective. The 488nm laser line was set at 10%, image exposure set to 500ms, and the Z-stacks were obtained for 4µm with 0.2µm step-size. A 525nm center, 50nm bandwidth emission filter was used for all fluorescence images. Images were analyzed using Volocity quantitation software (Perkin Elmer). Find object module was used to identify objects with the threshold set to 18.4% for fluorescence intensity. Images were linearly contrast enhanced for visualization. Quantification was performed on raw data from which integrated pixel intensity was used for all further analyses.
Co-immunoprecipitation -50 ml cultures of cells expressing different combinations of wild type or mutant HA-STE18 and STE5-GFP were grown to an OD of 0.8 and treated with 10µM pheromone for 20 mins. Cells were then harvested, washed with water, snap-chilled in liquid nitrogen and stored in -80C. Cell pellets were subjected to glass bead lysis in buffer containing 20 mM Tris-HCl (pH 8.0), 150 mM NaCl, 2 mM MgCl2, 0.1% Triton X-100 (Sigma Aldrich), 5% glycerol, 1 mM TCEP, 0.5mM PMSF, and protease and phosphatase inhibitor tablets (Pierce #A32959). The soluble protein extract was then collected in a fresh tube after centrifugation at 21,000xg for 10 min. For immunoprecipitation of Ste5-GFP, anti-GFP mAb-agarose (MBL, #D153-8) pre-equilibrated with the lysis buffer was added to each lysate of fixed concentration and total mass followed by incubation with gentle agitation at 4C for 3 hours. Beads were washed with lysis buffer to reduce non-specifically bound proteins. Washed beads were resuspended in 1x SDS-PAGE buffer and boiled for 3 min to elute bound protein. Eluted proteins were separated by SDS-PAGE and immunoblotting with anti-GFP (Invitrogen, A11122) and anti-HA.
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Coyle, S.M., Flores, J., and Lim, W.A. (2013) ) . The greatest degree of synergy between Ste18/Ste5 elements were observed for Fus3 peak activation time (top  table) . In contrast, peak activation amplitude results from additive rather than synergistic effects of the two elements (since the sum of effects for removal of either Ste18 or Ste5 elements alone were nearly equal to the elimination of both elements together) (middle table) . Table S3 . Best-fit values for pheromone dose-response of independent or combined mutation of Ste18 phosphosites and Ste5 FBD . Related to Figure 5 . Sigmoidal dose-response curves with variable slope were fit to data shown in Figure 4 to estimate switch or graded morphological responses for each indicated yeast strain. A constraint value of 100 was applied to the top of the curve. Each test result is color matched to each compared strain for which statistically significant differences were observed. Black asterisks indicate significant difference from all other strains within the same time point. Figure  S4 ) were resolved on a phos-tag gel and immunoblotted with anti-Fus3 antibody. (A) Representative immunoblot showing the mono-phosphorylated (pFus3), di-phosphorylated (ppFus3) and non-phosphorylated Fus3 (Fus3). The relative abundance of Fus3 di-phosphorylation (ppFus3) confirms results from di-phospho-specific antibody blots shown in Figures 2 and 3 . This same trend was also observed for mono-phosphorylated Fus3 (pFus3). (B) Quantification of the band intensity of ppFus3, pFus3 and Fus3 is denoted as percentage of total Fus3 in each lane. (C) Graphical representation of the percentage of mono-and di-phosphorylated Fus3 from B. Before pheromone stimulation (time 0), neither pFus3 nor ppFus3 are detectable in Ste18 WT /Ste5 ND cells since the Ste5 FBD is needed for allosteric activation and mono-phosphorylation of Fus3. Both pFus3 and ppFus3 are significantly elevated in Ste18 3A /Ste5 ND cells and moderately elevated in Ste18 3A /Ste5 WT cells (relative to wild type cells) before the addition of pheromone, suggesting that phosphorylation of both proteins contributes to the inhibition of MAPK activation in the absence of pheromone. Consistent with this conclusion, we found that pFus3 was diminished or completely abolished in wild type or Ste18 3E /Ste5 ND cells, which mimics partial inhibition. Overall, these data suggest that either Ste18 Nt phosphorylation or Ste5 phosphorylation (controlled by Fus3 docking on Ste5), can effectively inhibit the aberrant di-phosphorylation of Fus3 in the absence of pheromone. Furthermore, simultaneously preventing phosphorylation on both proteins results in aberrant di-phosphorylation of Fus3 in the absence of pheromone. Data represent the mean ± SD for 3 independent colonies. Figure 3 ) were treated with 10µM -factor for the desired time. Protein extracts were separated by 7.5% SDS-PAGE until higher molecular weight markers (110-160kDa markers of the Novex Sharp pre-stained protein standard [LC5800]) were well resolved, which was ~20 minutes after the loading dye ran off of the gel. Ste5-GFP ran at its expected size of approximately 130kDa (Ste5: 102 kDa and GFP: 27kDa). The abundance of Ste5 was probed using anti-GFP antibody. LC: loading control. 
